Carcao, Manuel
57  results:
Search for persons X
?
2

Simoctocog alfa (Nuwiq®) in previously untreated patients w..:

Mathias, Mary ; Abraham, Aby ; Belletrutti, Mark...
info:eu-repo/semantics/altIdentifier/doi/10.1111/ejh.14040.  , 2023
 
?
3

Simoctocog alfa (Nuwiq®) in previously untreated patients w..:

Mathias, Mary ; Abraham, Aby ; Belletrutti, Mark...
info:eu-repo/semantics/altIdentifier/doi/10.1111/ejh.14040.  , 2023
 
?
5

Simoctocog alfa (Nuwiq®) in previously untreated patients w..:

Mathias, Mary ; Abraham, Aby ; Belletrutti, Mark...
info:eu-repo/semantics/altIdentifier/doi/10.1111/ejh.14040.  , 2023
 
?
 
?
8

Simoctocog alfa (Nuwiq®) in previously untreated patients w..:

Mathias, Mary ; Abraham, Aby ; Belletrutti, Mark...
info:eu-repo/semantics/altIdentifier/doi/10.1111/ejh.14040.  , 2023
 
?
13

Safety and effectiveness of recombinant factor XIII-A 2 in ..:

Poulsen, Lone Hvitfeldt ; Kerlin, Bryce A ; Castaman, Giancarlo...
Poulsen , L H , Kerlin , B A , Castaman , G , Molinari , A C , Menegatti , M , Nugent , D , Dey , S , Garly , M L & Carcao , M 2022 , ' Safety and effectiveness of recombinant factor XIII-A 2 in congenital factor XIII deficiency : Real-world evidence ' , Research and Practice in Thrombosis and Haemostasis , vol. 6 , no. 2 , e12628 . https://doi.org/10.1002/rth2.12628.  , 2022
 
1-15